Prognostic significance of vascular endothelial growth factor, basic fibroblastic growth factor, and microvessel density and their relation to cell proliferation in B-cell non-Hodgkin's lymphoma

被引:15
作者
Alshenawy, Hanan AlSaeid [1 ]
机构
[1] Tanta Univ, Fac Med, Dept Pathol, Tanta, Egypt
关键词
VEGF; b-FGF; Angiogenesis; Microvessel density; B-cell non-Hodgkin's lymphoma; TUMOR ANGIOGENESIS; MULTIPLE-MYELOMA; BREAST-CANCER; BONE-MARROW; EXPRESSION; LEUKEMIA; RECEPTORS; SPECTRUM; STAGE; VEGF;
D O I
10.1016/j.anndiagpath.2009.12.011
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Vascular endothelial growth factor (VEGF) and basic fibroblastic growth factor (b-FGF) have been described as essential cytokines in the regulation of angiogenesis. Their elevation has been associated with an unfavorable outcome in different neoplasms. However, their role in angiogenesis and proliferation in B-cell non-Hodgkin's lymphoma (B-NHL) is unclear. Seventy cases of B-NHL besides 5 cases with reactive lymphadenitis were collected randomly and classified according to World Health Organization classification, Ann Arbor staging. They were subjected to immunostaining using VEGF, b-FGF, CD34, and Ki67 markers. There were a positive correlation between the proliferation and aggressiveness of the tumor as measured with Ki67 and both VEGF and b-FGF, and this was reflected on the stromal increase in microvessel density as measured by CD34. In conclusion, as the tumor becomes more aggressive, it also becomes independent of stromal paracrine factors by the establishment of an autocrine VEGF and b-FGF stimulation that can increase its angiogenesis and proliferation. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 34 条
[1]  
Arias V, 2000, LEUKEMIA LYMPHOMA, V40, P157
[2]  
BERTHOLD SMD, 2004, NEW ENGL J MED, V351, P250
[3]  
Blanckaert VD, 1998, CLIN CANCER RES, V4, P2939
[4]  
DITA G, 2007, AM J PATHOL, V170, P1362
[5]  
EUNICE S, 2004, BLOOD, V104, P2893
[6]  
FRANCESCO B, 2000, BLOOD
[7]   Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia [J].
Gruber, G ;
Schwarzmeier, JD ;
Shehata, M ;
Hilgarth, M ;
Berger, R .
BLOOD, 1999, 94 (03) :1077-1085
[8]  
GRZEGORZ M, 2004, FOLIA HISTOCHEM CYTO, V42, P241
[9]   World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849
[10]   Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma [J].
Ho, CL ;
Sheu, LF ;
Li, CY .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (04) :316-321